Pricing Log in Create free account

Aclaris Therapeutics, Inc. (ACRS) vs Entera Bio Ltd. (ENTX)

Aclaris Therapeutics, Inc. and Entera Bio Ltd. are both Biotechnology companies. Aclaris Therapeutics, Inc. and Entera Bio Ltd. are of similar size ($513.7M and $481.5M). Entera Bio Ltd. grew revenue faster over the last twelve months: 66.4% against −51.0%. Entera Bio Ltd. has the higher net margin (0.00% vs −921.5%) and the higher return on invested capital (0.00% vs −163.4%). Across the 17 metrics below, Aclaris Therapeutics, Inc. leads on 9 and Entera Bio Ltd. on 8.

Valuation

Metric ACRS ENTX Biotechnology median
P/E n/m n/m 8.50
P/S 56.96 606.32 9.71
P/B 3.76 18.61 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 47.13 541.12 9.21
Earnings yield (17.68%) (13.06%) (33.15%)
Free cash flow yield (13.28%) (8.13%) (25.50%)

Profitability

Metric ACRS ENTX Biotechnology median
Gross margin 12.90% 0.00% 65.16%
Operating margin (1,050.16%) 0.00% 0.00%
Net margin (921.50%) 0.00% 0.00%
Free cash flow margin (756.50%) 0.00% 0.00%
Return on equity (59.10%) (138.92%) (56.36%)
Return on assets (41.07%) (87.02%) (48.04%)
Return on invested capital (163.35%) 0.00% 0.00%

Growth

Metric ACRS ENTX Biotechnology median
Revenue growth (TTM) (51.04%) 66.42% 6.02%
EPS growth (last fiscal year) 69.01% 0.00% 30.26%
Revenue growth, 5-year CAGR 3.84% (29.19%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ACRS ENTX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 3.46 8.98 4.72
Net debt to EBITDA 1.20 1.29 0.96

Dividend

Metric ACRS ENTX Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ACRS ENTX Biotechnology median
Market cap 513.72m 481.53m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack